vs
Side-by-side financial comparison of PBF Energy Inc. (PBF) and Walgreens Boots Alliance (WBA). Click either name above to swap in a different company.
Walgreens Boots Alliance is the larger business by last-quarter revenue ($39.0B vs $7.9B, roughly 4.9× PBF Energy Inc.). PBF Energy Inc. runs the higher net margin — 2.5% vs -0.4%, a 3.0% gap on every dollar of revenue. On growth, PBF Energy Inc. posted the faster year-over-year revenue change (11.9% vs 7.2%). Over the past eight quarters, Walgreens Boots Alliance's revenue compounded faster (4.9% CAGR vs -4.9%).
PBF Energy Inc. is a petroleum refining and logistics company that produces and sells transportation fuels, heating oils, lubricants, petrochemical feedstocks, and other petroleum products. The company owns and operated 6 refineries throughout the United States, located in Chalmette, Louisiana; Toledo, Ohio; Paulsboro, New Jersey; the Delaware City Refinery in Delaware City; Torrance, California; Martinez, California. PBF produces a range of products including gasoline, ultra-low-sulfur diese...
Walgreens Boots Alliance, Inc. (WBA) was an American multinational holding company headquartered in Deerfield, Illinois. The company was formed on December 31, 2014, after Walgreens bought the 55% stake in Alliance Boots that it did not already own. The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion. Walgreens had previously purchased 45% of the company for $4.0 billion and 83.
PBF vs WBA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.9B | $39.0B |
| Net Profit | $200.2M | $-175.0M |
| Gross Margin | 3.5% | 16.7% |
| Operating Margin | 3.8% | 0.1% |
| Net Margin | 2.5% | -0.4% |
| Revenue YoY | 11.9% | 7.2% |
| Net Profit YoY | 149.4% | -150.9% |
| EPS (diluted) | $1.65 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $7.9B | — | ||
| Q4 25 | $7.1B | — | ||
| Q3 25 | $7.7B | — | ||
| Q2 25 | $7.5B | $39.0B | ||
| Q1 25 | $7.1B | $38.6B | ||
| Q4 24 | $7.4B | $39.5B | ||
| Q3 24 | $8.4B | $37.5B | ||
| Q2 24 | $8.7B | $36.4B |
| Q1 26 | $200.2M | — | ||
| Q4 25 | $78.4M | — | ||
| Q3 25 | $170.1M | — | ||
| Q2 25 | $-5.2M | $-175.0M | ||
| Q1 25 | $-401.8M | $-2.9B | ||
| Q4 24 | $-289.3M | $-265.0M | ||
| Q3 24 | $-285.9M | $-3.0B | ||
| Q2 24 | $-65.2M | $344.0M |
| Q1 26 | 3.5% | — | ||
| Q4 25 | -1.8% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | -0.8% | 16.7% | ||
| Q1 25 | -5.9% | 18.0% | ||
| Q4 24 | -4.2% | 17.2% | ||
| Q3 24 | -3.4% | 16.7% | ||
| Q2 24 | 0.1% | 17.8% |
| Q1 26 | 3.8% | — | ||
| Q4 25 | 1.8% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 0.6% | 0.1% | ||
| Q1 25 | -7.2% | -14.4% | ||
| Q4 24 | -5.2% | -0.6% | ||
| Q3 24 | -4.6% | -2.6% | ||
| Q2 24 | -0.9% | 0.3% |
| Q1 26 | 2.5% | — | ||
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | -0.1% | -0.4% | ||
| Q1 25 | -5.7% | -7.4% | ||
| Q4 24 | -3.9% | -0.7% | ||
| Q3 24 | -3.4% | -8.0% | ||
| Q2 24 | -0.7% | 0.9% |
| Q1 26 | $1.65 | — | ||
| Q4 25 | $0.74 | — | ||
| Q3 25 | $1.45 | — | ||
| Q2 25 | $-0.05 | $-0.20 | ||
| Q1 25 | $-3.53 | $-3.30 | ||
| Q4 24 | $-2.41 | $-0.31 | ||
| Q3 24 | $-2.49 | $-3.48 | ||
| Q2 24 | $-0.56 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $541.8M | $830.0M |
| Total DebtLower is stronger | — | $7.4B |
| Stockholders' EquityBook value | $5.7B | $7.2B |
| Total Assets | $14.7B | $69.4B |
| Debt / EquityLower = less leverage | — | 1.03× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $541.8M | — | ||
| Q4 25 | $527.9M | — | ||
| Q3 25 | $482.0M | — | ||
| Q2 25 | $590.7M | $830.0M | ||
| Q1 25 | $468.6M | $1.1B | ||
| Q4 24 | $536.1M | $1.2B | ||
| Q3 24 | $976.7M | $3.1B | ||
| Q2 24 | $1.4B | $703.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $7.4B | ||
| Q1 25 | — | $8.0B | ||
| Q4 24 | — | $8.1B | ||
| Q3 24 | — | $9.6B | ||
| Q2 24 | — | — |
| Q1 26 | $5.7B | — | ||
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.2B | — | ||
| Q2 25 | $5.1B | $7.2B | ||
| Q1 25 | $5.1B | $7.1B | ||
| Q4 24 | $5.5B | $9.9B | ||
| Q3 24 | $5.9B | $10.4B | ||
| Q2 24 | $6.3B | $13.6B |
| Q1 26 | $14.7B | — | ||
| Q4 25 | $13.0B | — | ||
| Q3 25 | $13.0B | — | ||
| Q2 25 | $13.0B | $69.4B | ||
| Q1 25 | $13.0B | $70.2B | ||
| Q4 24 | $12.7B | $78.5B | ||
| Q3 24 | $13.1B | $81.0B | ||
| Q2 24 | $14.1B | $83.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 0.81× | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $584.0M |
| Free Cash FlowOCF − Capex | — | $336.0M |
| FCF MarginFCF / Revenue | — | 0.9% |
| Capex IntensityCapex / Revenue | 4.0% | 0.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $580.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $366.6M | — | ||
| Q3 25 | $25.7M | — | ||
| Q2 25 | $191.1M | $584.0M | ||
| Q1 25 | $-661.4M | $-199.0M | ||
| Q4 24 | $-329.7M | $-140.0M | ||
| Q3 24 | $-68.0M | $1.3B | ||
| Q2 24 | $425.3M | $604.0M |
| Q1 26 | — | — | ||
| Q4 25 | $77.0M | — | ||
| Q3 25 | $-122.8M | — | ||
| Q2 25 | $35.0M | $336.0M | ||
| Q1 25 | $-772.4M | $-418.0M | ||
| Q4 24 | $-425.7M | $-424.0M | ||
| Q3 24 | $-169.8M | $1.1B | ||
| Q2 24 | $371.8M | $327.0M |
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | — | ||
| Q3 25 | -1.6% | — | ||
| Q2 25 | 0.5% | 0.9% | ||
| Q1 25 | -10.9% | -1.1% | ||
| Q4 24 | -5.8% | -1.1% | ||
| Q3 24 | -2.0% | 2.9% | ||
| Q2 24 | 4.3% | 0.9% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 4.1% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 2.1% | 0.6% | ||
| Q1 25 | 1.6% | 0.6% | ||
| Q4 24 | 1.3% | 0.7% | ||
| Q3 24 | 1.2% | 0.7% | ||
| Q2 24 | 0.6% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.68× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBF
Segment breakdown not available.
WBA
| Pharmacy | $24.4B | 63% |
| Retail | $6.3B | 16% |
| International Reportable Segment | $6.2B | 16% |
| US Healthcare | $2.1B | 5% |
